Financials

  • Market Capitalization 1.54 B
  • Employee 27
  • Founded 2015
  • CEO N/A
  • Website www.lbpharma.us
  • Headquarter Delaware, United States
  • FIGI BBG00XNP5MQ4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2170
BCAX
Bicara Therapeutics Inc. - Common Stock
23.43 USD-5.64%-1.22%-12.74%+62.26%1.55 B USD
2171
XERS
Xeris Biopharma Holdings, Inc. - Common Stock
8.48 USD-1.40%-2.53%+4.05%+9.28%1.55 B USD
2179
NVAX
Novavax, Inc. - Common Stock
9.26 USD+2.32%+4.28%+25.82%+25.30%1.53 B USD
2184
INVA
Innoviva, Inc. - Common Stock
20.97 USD+0.05%-0.47%0.00%+17.68%1.51 B USD